Historical account of reperfusion therapy and the development of cardioprotection beyond reperfusion - Summary - MDSpire

A Historical Perspective on Reperfusion Therapy and Advancements in Cardioprotection Beyond Reperfusion

  • By

  • Gerd Heusch

  • Petra Kleinbongard

  • Bernard J. Gersh

  • July 17, 2026

Share

Objective:

To provide a historical overview of the development and impact of reperfusion therapy in the management of acute myocardial infarction (AMI).

Approach:
  • Introduction: Discusses the historical context of AMI treatment and the evolution of reperfusion therapy, highlighting its impact on in-hospital mortality rates.
  • Early clinical use of intravenous thrombolysis: Describes the initial use of intravenous streptokinase for thrombolysis in AMI and the delayed adoption despite positive outcomes.
  • Experimental recognition of reperfusion to reduce infarct size: Details early experimental studies demonstrating the benefits of reperfusion in reducing infarct size in animal models.
  • Intracoronary thrombolysis and mechanical coronary recanalization: Covers the development of intracoronary thrombolysis and mechanical recanalization techniques in AMI treatment.
  • Firm evidence for timely reperfusion from clinical trials: Summarizes key clinical trials that established the efficacy of various reperfusion strategies, including thrombolysis and primary angioplasty.
Key Findings:
  • Reperfusion therapy has reduced in-hospital mortality from about 20% to 5% or less in STEMI patients.
  • Early studies on thrombolysis showed improved outcomes but were not widely adopted for decades.
  • Experimental studies established the importance of timely reperfusion in reducing infarct size.
  • Clinical trials confirmed the superiority of mechanical recanalization over thrombolysis in terms of mortality and myocardial salvage.
Interpretation:

The historical development of reperfusion therapy illustrates the importance of timely intervention in AMI management and the evolution of treatment strategies based on clinical evidence.

Limitations:
  • The article does not address the long-term outcomes of reperfusion therapy beyond initial mortality rates.
  • It lacks a comprehensive analysis of the socio-economic factors influencing the adoption of reperfusion strategies.
Conclusion:

Reperfusion therapy has significantly advanced the treatment of AMI, with ongoing developments in pharmacological and mechanical approaches.

Original Source(s)

Related Content